1321 related articles for article (PubMed ID: 21574972)
1. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
Grönhagen CM; Fored CM; Granath F; Nyberg F
Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of cutaneous lupus erythematosus and the associated risk of systemic lupus erythematosus: a nationwide cohort study in Denmark.
Petersen MP; Möller S; Bygum A; Voss A; Bliddal M
Lupus; 2018 Aug; 27(9):1424-1430. PubMed ID: 29788808
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of cancer among 3663 patients with cutaneous lupus erythematosus: a Swedish nationwide cohort study.
Grönhagen CM; Fored CM; Granath F; Nyberg F
Br J Dermatol; 2012 May; 166(5):1053-9. PubMed ID: 22175767
[TBL] [Abstract][Full Text] [Related]
5. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.
Ståhl-Hallengren C; Jönsen A; Nived O; Sturfelt G
J Rheumatol; 2000 Mar; 27(3):685-91. PubMed ID: 10743809
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous manifestations and serological findings in 260 patients with systemic lupus erythematosus.
Grönhagen CM; Gunnarsson I; Svenungsson E; Nyberg F
Lupus; 2010 Sep; 19(10):1187-94. PubMed ID: 20501526
[TBL] [Abstract][Full Text] [Related]
7. A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus.
Popovic K; Nyberg F; Wahren-Herlenius M; Nyberg F
Arthritis Rheum; 2007 Jan; 56(1):255-64. PubMed ID: 17195229
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous lupus erythematosus: clinical and immunological study of 308 patients stratified by gender.
Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
Clin Exp Dermatol; 2010 Oct; 35(7):729-35. PubMed ID: 20015282
[TBL] [Abstract][Full Text] [Related]
9. Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus.
Schmitt V; Meuth AM; Amler S; Kuehn E; Haust M; Messer G; Bekou V; Sauerland C; Metze D; Köpcke W; Bonsmann G; Kuhn A
Br J Dermatol; 2010 Jan; 162(1):64-73. PubMed ID: 19712116
[TBL] [Abstract][Full Text] [Related]
10. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
Hesselvig JH; Ahlehoff O; Dreyer L; Gislason G; Kofoed K
Lupus; 2017 Jan; 26(1):48-53. PubMed ID: 27235406
[TBL] [Abstract][Full Text] [Related]
12. Does cutaneous lupus erythematosus have more favorable pregnancy outcomes than systemic disease? A two-center study.
Hamed HO; Ahmed SR; Alzolibani A; Kamal MM; Mostafa MS; Gamal RM; Atallah DA; Abd-El-Aall DE
Acta Obstet Gynecol Scand; 2013 Aug; 92(8):934-42. PubMed ID: 23621378
[TBL] [Abstract][Full Text] [Related]
13. The differential panorama of clinical features of lupus erythematosus patients with different onset ages: a cross-sectional multicenter study from China.
Yu Y; Jin H; Zhou S; Zhao M; Wu H; Long H; Fu S; Wu R; Yin H; Liao J; Luo S; Liu Y; Zhang Q; Zhang P; Tan Y; Huang X; Li F; Lin G; Lu Q
Clin Rheumatol; 2023 Sep; 42(9):2353-2367. PubMed ID: 37311918
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.
Bengtsson C; Ohman ML; Nived O; Rantapää Dahlqvist S
Lupus; 2012 Apr; 21(4):452-9. PubMed ID: 22065097
[TBL] [Abstract][Full Text] [Related]
15. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus.
Järvinen TM; Hellquist A; Koskenmies S; Einarsdottir E; Koskinen LL; Jeskanen L; Berglind L; Panelius J; Hasan T; Ranki A; Kere J; Saarialho-Kere U
Exp Dermatol; 2010 Feb; 19(2):123-31. PubMed ID: 19758313
[TBL] [Abstract][Full Text] [Related]
17. Association Between Drug Use and Subsequent Diagnosis of Lupus Erythematosus.
Haugaard JH; Kofoed K; Gislason G; Dreyer L; Egeberg A
JAMA Dermatol; 2020 Nov; 156(11):1199-1207. PubMed ID: 32876672
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE).
Biazar C; Sigges J; Patsinakidis N; Ruland V; Amler S; Bonsmann G; Kuhn A;
Autoimmun Rev; 2013 Jan; 12(3):444-54. PubMed ID: 23000206
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous lupus erythematosus is associated with an increased risk of cardiac and vascular diseases: a large-scale, propensity-matched global retrospective cohort study.
Olbrich H; Kridin K; Zirpel H; Sadik CD; Terheyden P; Thaçi D; Ludwig RJ; Boch K
EBioMedicine; 2023 Jul; 93():104639. PubMed ID: 37285617
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous manifestations of systemic lupus erythematosus.
Yell JA; Mbuagbaw J; Burge SM
Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
